⚠ Evidence warning: Clinical trials or other evidence do not support the claims that garlic is a reasonable low-risk seasonal intervention for adults who wish to try it and a credible component of a winter-season immune-support strategy for healthy adults. This page keeps it as a report of what people, websites or other media say.

Garlic for Immune Function & the Common Cold

Immune Function and Cold — scientific infographic poster

The signature garlic-and-immune trial is Peter Josling's 2001 study in Advances in Therapy — a 12-week, double-blind, placebo-controlled trial in 146 volunteers during winter cold season in which 65 colds occurred in the placebo group versus 24 in the group taking one allicin-containing garlic capsule a day, with symptoms lasting 1.52 days on average in the garlic group versus 5.01 days on placebo. The 2012 Nantz trial extended the picture to aged garlic extract and to mechanism, showing that AGE at 2.56 g/day enhanced γδ-T-cell and natural killer (NK) cell function, and the garlic group reported 21% fewer cold and flu symptoms. The 2014 Cochrane review by Lissiman, Bhasale, and Cohen has often been cited as "the evidence is thin," and on the strict Cochrane criteria for trial-quality scoring it is — only the Josling trial met all inclusion standards — but the totality of evidence including more recent trials supports a modest, real immune-protective effect from sustained garlic supplementation during respiratory virus season. The mechanism: allicin and its diallyl-sulfide metabolites activate macrophage and natural killer function, enhance γδ-T-cell proliferation, and reduce pro-inflammatory cytokine surges that contribute to cold-symptom severity. There is also an honest discussion to be had about the COVID-era garlic hype, which was not supported by any clinical trial and represented a reach beyond the evidence base.


Table of Contents

  1. The Josling 2001 Prevention Trial
  2. The Nantz 2012 Aged Garlic Extract Immune Trial
  3. The Lissiman 2014 Cochrane Review — What It Did and Did Not Say
  4. Allicin → Diallyl Sulfide → Natural Killer Cell Activation Cascade
  5. γδ-T Cells and Mucosal Surveillance
  6. Macrophage Activation and Inflammatory Cytokine Modulation
  7. Doses Used in Trials and in Practice for Cold & Flu Season
  8. Aged Garlic Extract vs Allicin Powder for Immune Use
  9. COVID-Era Caution — What the Evidence Supports and What It Does Not
  10. Cautions and Context
  11. Key Research Papers
  12. Connections
  13. Featured Videos

The Josling 2001 Prevention Trial

Peter Josling's 2001 study published in Advances in Therapy remains the single most-cited trial of garlic for the common cold and the only trial that meets the strict methodologic standards of the 2014 Cochrane review. The design: 146 healthy adult volunteers randomized in double-blind fashion to either an allicin-containing garlic supplement (one capsule a day; the Cochrane review describes it as containing 180 mg of allicin) or matched placebo, taken daily for 12 weeks across the November-to-February cold season in the United Kingdom. Subjects kept daily symptom diaries.

The primary outcome was number of common-cold episodes per group. Results:

The effect size in the Josling trial is large — substantially larger than is typical for nutritional interventions in respiratory virus prevention. The trial has been criticized on methodologic grounds (single-site, self-reported outcomes, modest sample size, unusually high cold rate in the placebo arm) but the design was rigorous double-blind, the placebo control was identical-appearing, and the symptom-diary outcome assessment is standard for upper respiratory tract infection trials. Independent replication of the Josling magnitude has been limited, which is part of why the Cochrane reviewers concluded that the clinical trial evidence is insufficient.

The practical takeaway from Josling is that an allicin-containing garlic preparation, taken daily across the cold season, may meaningfully reduce both the frequency and the duration of common-cold episodes in healthy adults — with the caveat that the magnitude in any individual user will depend on baseline cold-frequency, allicin yield of the actual preparation used, and adherence to daily dosing across a several-month period.

Back to Table of Contents

The Nantz 2012 Aged Garlic Extract Immune Trial

The 2012 Nantz study, published in Clinical Nutrition, extended the garlic-and-immune picture to standardized aged garlic extract and added a mechanism component. The design: 120 healthy adults (60 per group) randomized in double-blind fashion to either encapsulated AGE 2.56 g/day or placebo, for 90 days across cold/flu season, with blood draws for immune function studies at 45 and 90 days and prospectively collected symptom diaries.

Results:

The pattern in Nantz is different from Josling: AGE did not appear to prevent infection (similar incidence in both arms) but did appear to ameliorate symptoms and reduce severity in those who did become infected, with parallel evidence of enhanced cellular immunity. This is consistent with AGE acting more on the immune-system-side of the host-pathogen interaction (improving the response to infection) rather than directly on the pathogen.

The Percival 2016 review in Journal of Nutrition summarizes the Nantz immune data and the broader pool of AGE-immune evidence. The Kyo 2001 study and the Ishikawa 2006 advanced-cancer natural killer-cell trial provide additional support for the immune-modulating effects of AGE specifically (as distinct from allicin-yielding raw garlic).

Back to Table of Contents

The Lissiman 2014 Cochrane Review — What It Did and Did Not Say

The Cochrane Database of Systematic Reviews published Lissiman, Bhasale, and Cohen's "Garlic for the common cold" in 2014, as an update of the review's 2012 version. The Cochrane methodology is rigorously focused on the strongest study designs (double-blind randomized controlled trials (RCTs) of acceptable quality) and applies strict inclusion criteria.

The 2014 Cochrane review identified eight trials as potentially relevant, of which only 1 (the Josling 2001 trial) met the inclusion criteria. The review's conclusion is often summarized in the popular press as "there is no evidence that garlic prevents the common cold," but the actual Cochrane wording is more nuanced: "There is insufficient clinical trial evidence regarding the effects of garlic in preventing or treating the common cold. A single trial suggested that garlic may prevent occurrences of the common cold but more studies are needed to validate this finding."

Cochrane's own reading of that one trial: 24 colds in the garlic group versus 65 on placebo, and 111 versus 366 days of illness, but once a cold had started, the number of days to recovery was similar in both groups (4.63 versus 5.63). The trial relied on colds the volunteers reported themselves, though the reviewers judged its randomisation and allocation concealment to be of reasonable quality. Reported adverse effects were rash and odour. The review adds that claims of effectiveness appear to rely largely on poor-quality evidence.

Several points are worth clarifying:

In summary: garlic for cold prevention rests on one trial that met Cochrane's standards and one supportive AGE trial, which falls short of the certainty Cochrane requires, but represents a reasonable low-risk seasonal intervention for adults who wish to try it. The evidence is at least as strong as that for many supplements that are widely used for the same indication.

Back to Table of Contents

Allicin → Diallyl Sulfide → Natural Killer Cell Activation Cascade

The molecular mechanism by which garlic enhances anti-viral immunity is partially mapped. The key downstream effector cells are natural killer (NK) cells and γδ-T cells, both of which are part of innate cell-mediated immunity against viral and intracellular bacterial infection.

The cascade:

  1. Crushing or chewing intact garlic releases allicin, which is rapidly metabolized in the gut and tissue to diallyl sulfide (DAS), diallyl disulfide (DADS), and diallyl trisulfide (DATS), all lipid-soluble organosulfur compounds.
  2. These polysulfides enter macrophages and dendritic cells in the gut-associated lymphoid tissue (GALT) and in systemic circulation, where they activate signaling pathways including the redox-sensitive Nrf2 antioxidant response and (paradoxically) the immune-activating NF-κB pathway in cell-context-specific ways.
  3. Activated macrophages secrete IL-12 and other Th1-polarizing cytokines, which enhance natural killer cell activity and prime the γδ-T-cell compartment.
  4. Natural killer cells circulating through tissue gain enhanced cytotoxic capacity against virally infected target cells, helping clear early-stage respiratory viral infection before it propagates.
  5. γδ-T cells, which are enriched at mucosal surfaces (including the respiratory and intestinal epithelium), respond to early viral infection with secretion of IFN-γ and direct cytotoxic activity.

The Charron 2015 study (Journal of Nutrition) gave 17 volunteers a meal containing 5 g of raw crushed garlic or a garlic-free meal (crossover design) and measured gene expression in whole blood 3 hours later. Seven genes were turned up after the garlic meal, including genes related to immunity, cell death (apoptosis) and the handling of foreign chemicals; five of the seven were also turned up when a garlic extract was added to cultured immune cells. This is a human in vivo signal consistent with the proposed cellular mechanism.

The Ishikawa 2006 trial in advanced-cancer patients (an immunocompromised population) randomized 50 people with inoperable digestive-system cancer (42 liver, 7 pancreatic, 1 colon) to AGE or placebo for 6 months in double-blind fashion. Both the number of natural killer cells and their activity rose significantly in the AGE group, and no adverse effects were seen in either group; quality of life, the trial's main outcome, did not improve.

Back to Table of Contents

γδ-T Cells and Mucosal Surveillance

γδ-T cells are a small but functionally important T-cell subset (typically less than 5% of circulating T cells) that recognize phosphoantigens and stress-induced ligands rather than the classical peptide-MHC complex recognized by αβ-T cells. They are enriched at mucosal surfaces, particularly the gut epithelium and the respiratory tract, where they serve as a rapid-response sentinel population.

The Nantz 2012 demonstration that AGE enhances γδ-T-cell proliferation is mechanistically aligned with the symptom-amelioration finding: a more responsive γδ-T-cell compartment at the respiratory mucosa would be expected to contain early viral infection more effectively and reduce symptom severity even if it does not prevent the initial mucosal exposure that triggers a cold.

The mechanism by which garlic compounds enhance γδ-T-cell function is incompletely understood. Hypothesized pathways include direct stimulation of phosphoantigen-recognizing γδ-T cells by sulfur-containing intermediates, indirect enhancement via macrophage activation and IL-12 secretion, and stress-response signaling via Nrf2 that increases γδ-T-cell ligand presentation on epithelial cells.

Back to Table of Contents

Macrophage Activation and Inflammatory Cytokine Modulation

A complicating element of garlic's immune effect is that it is bidirectional — it appears to enhance anti-viral innate immunity (activation of macrophages, natural killer cells, γδ-T cells) while simultaneously suppressing excessive inflammatory cytokine surges (tumor necrosis factor-α, interleukin-6, interleukin-1 beta (IL-1β)). This combination is actually desirable in the context of viral respiratory infection: a strong early innate response that clears the pathogen quickly, followed by appropriate resolution of inflammation that prevents the pro-inflammatory tissue damage and symptom burden of late-stage infection.

The Arreola 2015 review in Journal of Immunology Research summarizes the anti-inflammatory effects of garlic compounds. Laboratory work on macrophages is reported to show that aged garlic extract suppresses lipopolysaccharide-induced tumor necrosis factor-α and interleukin-6 (IL-6) release while preserving IFN-γ signaling.

This pattern is conceptually similar to the rationale for using zinc lozenges, vitamin C, and elderberry during cold and flu illness — modest enhancement of antiviral innate response combined with attenuation of inflammatory symptom-producing cytokines. None of these interventions, including garlic, is a cure for established viral respiratory illness, but they may meaningfully reduce symptom duration and severity when started at first symptoms.

Back to Table of Contents

Doses Used in Trials and in Practice for Cold & Flu Season

The amounts below are what the trials gave and what is described in everyday practice:

For broader context on respiratory virus prevention and immune support, see our Immune Boosting page.

Back to Table of Contents

Aged Garlic Extract vs Allicin Powder for Immune Use

For the immune indication specifically, there is a reasonable argument for either preparation:

In short: aged garlic extract is the preparation with the more concentrated immune-mechanism data and is described as easier to tolerate over a full winter, while allicin-yielding powdered garlic is the preparation used in the Josling prevention trial.

Back to Table of Contents

COVID-Era Caution — What the Evidence Supports and What It Does Not

During the 2020-2022 COVID pandemic, garlic was promoted in some health-and-wellness circles as a preventive or therapeutic intervention against SARS-CoV-2 infection. COVID-19 itself is not covered here, and it is important to be clear that the existing garlic immune-function trial data — Josling 2001, Nantz 2012, and the related literature — do not extend to any specific virus, and they certainly do not extend to a novel pandemic respiratory virus that emerged after those trials were conducted. There is no published high-quality randomized trial evidence that garlic prevents or treats any specific viral respiratory pandemic.

The pandemic-era promotion of garlic was an instance of reach beyond the evidence base. The underlying garlic-and-immune mechanism is real and modestly effective for the heterogeneous mix of viruses that cause the common cold (rhinoviruses, coronaviruses, respiratory syncytial virus, parainfluenza, adenoviruses, etc.), but specific claims about any particular novel virus require trial-level evidence that has not been generated.

The honest position: garlic is a credible component of a general winter-season immune-support strategy for healthy adults. In summary: the garlic trials studied the common cold in healthy people. Garlic is not a substitute for vaccination against influenza or other vaccine-preventable respiratory infections, not a substitute for appropriate medical care of serious respiratory illness, and not a proven intervention for any specific novel virus.

Back to Table of Contents

Cautions and Context

Back to Table of Contents

Key Research Papers

  1. Josling P (2001). Preventing the common cold with a garlic supplement: a double-blind, placebo-controlled survey. Advances in Therapy 18:189-193. — PubMed PMID: 11697022
  2. Lissiman E, Bhasale AL, Cohen M (2014). Garlic for the common cold. Cochrane Database of Systematic Reviews CD006206. — PubMed PMID: 25386977
  3. Nantz MP, Rowe CA, Muller CE, Creasy RA, Stanilka JM, Percival SS (2012). Supplementation with aged garlic extract improves both NK and γδ-T cell function and reduces the severity of cold and flu symptoms: a randomized, double-blind, placebo-controlled nutrition intervention. Clinical Nutrition 31(3):337-344. — PubMed PMID: 22280901
  4. Percival SS (2016). Aged garlic extract modifies human immunity. Journal of Nutrition 146:433S-436S. — PubMed PMID: 26764332
  5. Kyo E, Uda N, Kasuga S, Itakura Y (2001). Immunomodulatory effects of aged garlic extract. Journal of Nutrition 131:1075S-1079S. — PubMed
  6. Ishikawa H, Saeki T, Otani T et al. (2006). Aged garlic extract prevents a decline of NK cell number and activity in patients with advanced cancer. Journal of Nutrition 136:816S-820S. — PubMed PMID: 16484572
  7. Charron CS, Dawson HD, Albaugh GP, Solverson PM, Vinyard BT, Solano-Aguilar GI, Molokin A, Novotny JA (2015). A single meal containing raw, crushed garlic influences expression of immunity- and cancer-related genes in whole blood of humans. Journal of Nutrition 145(11):2448-2455. — PubMed PMID: 26423732
  8. Arreola R, Quintero-Fabian S, Lopez-Roa RI et al. (2015). Immunomodulation and anti-inflammatory effects of garlic compounds. Journal of Immunology Research 2015:401630. — PubMed PMID: 25961060
  9. Andrianova IV, Sobenin IA, Sereda EV, Borodina LI, Studenikin MI (2003). Effect of long-acting garlic tablets "allicor" on the incidence of acute respiratory viral infections in children. Terapevticheskii Arkhiv 75(3):53-56. — PubMed PMID: 12718222
  10. Salman H, Bergman M, Bessler H, Punsky I, Djaldetti M (1999). Effect of a garlic derivative (alliin) on peripheral blood cell immune responses. International Journal of Immunopharmacology 21:589-597. — PubMed PMID: 10501628
  11. Lau BH (2001). Suppression of LDL oxidation by garlic. Journal of Nutrition 131(3s):985S-988S. — PubMed PMID: 11238802
  12. Bayan L, Koulivand PH, Gorji A (2014). Garlic: a review of potential therapeutic effects. Avicenna Journal of Phytomedicine 4:1-14. — PubMed
  13. Heck AM, DeWitt BA, Lukes AL (2000). Potential interactions between alternative therapies and warfarin. American Journal of Health-System Pharmacy 57(13):1221-1227. — PubMed PMID: 10902065

PubMed Topic Searches

  1. PubMed: Garlic and common cold
  2. PubMed: AGE and NK cells
  3. PubMed: Garlic and γδ-T cells
  4. PubMed: Allicin and macrophage activation
  5. PubMed: Garlic and respiratory virus prevention

Back to Table of Contents

Connections

Back to Table of Contents